Seasonal Affective Disorder (SAD) Market: Introduction

  • Seasonal affective disorder (SAD) is a type of depression that occurs during a certain season of the year. This disorder is related to fluctuation in seasons; especially occurs in winter, but some people could have it during summer. Seasonal affective disorder is most prevalent in women, people between the ages of 15 to 55, and people who live far from the equator where winter daylight hours are too short. Common symptoms of SAD are hopelessness, increased appetite, weight gain, loss of ability to concentrate, and social withdrawal, among others. Risk factors associated with this disorder are depressive disorders such as bipolar II disorder, bipolar I disorder, and others.

For More Info: https://www.transparencymarketresearch.com/seasonal-affective-disorder-sad-market.html

  • The global seasonal affective disorder (SAD) market can be segmented based on type, end-user, treatment, test type, and region. In terms of type, the global market can be classified into fall & winter, spring & summer, and others. Based on test type, the global seasonal affective disorder market can be categorized into psychological evaluation, lab tests, and others. The lab tests segment can be split into thyroid blood test, CBC, and others. The psychological evaluation segment can be segregated into personality tests, intelligence tests, attitude tests, achievement tests, neuropsychological tests, aptitude tests, vocational tests, direct observation tests, and others. In terms of treatment, the global seasonal affective disorder market can be divided into light therapy, psychotherapy, medications, counselling, and others. The medications segment can be bifurcated into antidepressants and others. The antidepressants sub-segment can be split into reuptake inhibitors (SSRIs) and others. The psychotherapy segment can be categorized into attachment-based psychotherapy, art therapy, behavioral therapy, cognitive analytical therapy (CAT), body psychotherapy, existential psychotherapy, gestalt therapy, and others. Based on end-user, the global market can be divided into clinics, hospitals, research institutes, and others.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82931

Key Drivers, Restraints, and Opportunities of Global Seasonal Affective Disorder (SAD) Market

  • A range of drugs and devices for treatment of seasonal affective disorder treatment are available in the market. Light therapy is utilized as the first line of therapy for seasonal affective disorder. Devices including light boxes, dawn stimulators, desk lamps, and sun visors are available in the market as light therapy for seasonal affective disorder.
  • Both branded and generic drugs for seasonal affective disorder treatment are available in developed and emerging economies. Citalopram and Buproban are the most commonly used drugs for seasonal affective disorder. A number of generic options for Citalopram and Buproban are also available in the market. Therefore, easy availability of seasonal affective disorder therapeutics is projected to drive the global market.
  • Experts have indicated that improper seasonal affective disorder therapeutics could have severe side effects. Dosage should be reduced in order to prevent these side effects. Adjunctive light therapy should begin with a dose titration of 7,000 lux, 4000 K blue enriched broad-spectrum white light for 15 minutes per day at midday around 2.30 pm. Then 15 minutes should be added each week until the dosage reaches a range of 45 minutes to 60 minutes per day. Average time to response and remission varies between four and six weeks. Continuous patient-physician engagement leads to better seasonal affective disorder treatment outcomes.

Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=82931

North America to Capture Major Share of Global Seasonal Affective Disorder (SAD) Market

  • North America is projected to dominate the global market in terms of share during the forecast period owing to rise in prevalence of seasonal depression. Around 5% of the population of the U.S. suffers from seasonal affective disorder. This is attributed to changing lifestyles and increase in awareness about seasonal depression and its treatment.
  • Asia Pacific has less prevalence of seasonal affective disorder. Rise in awareness, increase in the geriatric population, and surge in medical tourism in emerging economies such as China and India are expected to boost the growth of the market in the region.

Buy Seasonal Affective Disorder Market Report at - https://www.transparencymarketresearch.com/checkout.php?rep_id=82931&ltype=S

Key Players Operating in Global Seasonal Affective Disorder (SAD) Market

The global seasonal affective disorder (SAD) market is highly fragmented due to the presence of large number of key players. These players hold a major share in their respective regions. Leading players operating in the global seasonal affective disorder (SAD) market are:

  • Allergan plc
  • Eli Lily Company
  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Teva Pharmaceuticals, Inc.
  • Bausch Health Companies, Inc.
  • Hoffmann-La Roche AG
  • Mylan N.V.
  • Sanofi AG
  • Novartis AG
  • Janssen Pharmaceuticals, Inc.
  • The Sunbox Company
  • Verilux, Inc.
  • Carex Health
  • Northern Light Technologies
  • Beurer GmbH
  • Koninklijke Philips N.V.
  • Others

Global Seasonal Affective Disorder (SAD) Market: Research Scope

Global Seasonal Affective Disorder (SAD) Market, by Type

  • Fall & Winter
  • Spring & Summer
  • Others

Global Seasonal Affective Disorder (SAD) Market, by End-user

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

Global Seasonal Affective Disorder (SAD) Market, by Test Type

  • Lab Tests
    • CBC
    • Thyroid Blood Test
    • Others
  • Psychological Evaluation
    • Intelligence Test
    • Personality Test
    • Attitude Test
    • Achievement Test
    • Aptitude Test
    • Neuropsychological Test
    • Vocational Test
    • Direct Observation Test
    • Others
  • Others

Global Seasonal Affective Disorder (SAD) Market, by Treatment

  • Light Therapy
  • Medications
    • Antidepressants
      • SSRIs
      • Others
    • Others
  • Psychotherapy
    • Art Therapy
    • Attachment-based Psychotherapy
    • Behavioral Therapy
    • Body Psychotherapy
    • Cognitive Analytical Therapy (CAT)
    • Existential Psychotherapy
    • Gestalt Therapy
    • Others
  • Counselling
  • Others

Global Seasonal Affective Disorder (SAD) Market, by Region

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • France
    • K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This intelligence report by TMR is the outcome of intense study and rigorous assessment of various dynamics shaping the growth of the market. TMR nurtures a close-knit team of analysts, strategists, and industry experts who offer clients tools, methodologies, and frameworks to make smarter decisions. Our objective, insights, and actionable analytics provide CXOs and executives to advance their mission-critical priorities with confidence.

The scrutiny of the various forces impacting the dynamics of the market, and key and associated industries, guides enterprises in understanding various consumer propositions. Our clients leverage these insights and perspectives to enhance customer experience in the fast-paced business environment.

All our insights and perspectives are broadly based on 4 Pillars or Stages: ASBC-S, which offer an elaborate and customizable framework for the success of an organization. The essence and the roles of these in organizational successes are highlighted below:

  • Agenda for CXOs: TMR, through the study, sets the tone for agendas that are pertinent to CEOs, CFOs, CIOs, and other CXO executives of businesses operating in the market. The perspectives help our clients to bridge the gap between agenda and action plan. TMR strives to offer guidance to CXOs to undertake mission-critical activities empowered by various business analysis tools, and boost the performance of the organizations. The perspectives guide you to decide on your own marketing mix that align well with the policies, visions, and mission.
  • Strategic Frameworks: The study offers how organizations are setting both short-term and long-term strategic plans. Our team of experts collaborate and communicate with you to understand these to make your organizations sustainable and resilient during tough times. The insights help them decide sustainable competitive advantage for each business units.
  • Benchmarking for Deciding Target Markets and Brand Positioning: The assessments in the study provides a scrutiny of marketing channels and marketing mix. Our various teams work synergistically with you to help identify your actual and potential direct, indirect, and budget competition areas. Additionally, the study helps you decide most effective budgets for various processes and promotional activities. Furthermore, the study guides you to set benchmarks for integrating people and processes with the 4Ps of marketing. Eventually, this will empower you to find out unique propositioning strategies and niches.
  • Business Composability for Sustainability (C-S): Constant strategy planning for sustainability characterizing our C-S framework in the report has become more relevant than before in the face of disruptions caused by pandemics, recessions, boom and bust cycles, and changing geopolitical scenario. The TMR study offers a high level of customization to help you achieve business composability. Composable enterprises are increasingly gaining the attention of CXOs in order to help them combat market volatility. Our analysts and industry experts help you wade through such uncertainties and guide you to become a smart sustainable business in entirety.

 

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/